Glial cells are active components of the nervous system, possess numerous types of receptors for different neurotransmitters as well as a large variety of ion channels (Hamprecht, 1986; Barres Recei ved Apr. 3. 1995; revised July 14, 1995;  , 1990) . Equipped with this cellular machinery, glial cells closely associated with synapses react to the release of neurotransmitters during synaptic transmission (Chiu and Kriegler. 1994) . Synaptic activity generates Ca" responses in a network of astrocytes in the hippocampus (Dani et al., 1992) and the release of neurotransmitters by a single synapse at the frog neuromuscular junction is sufficient to induce CaL+ responses in perisynaptic glial cells (Jahromi et al., 1992; Reist and Smith, 1992) . These responses are mimicked by local applications of neurotransmitters present in synaptic vesicles (Jahromi et al., 1992 (Jahromi et al., , 1993 .
In addition to ACh, a large concentration of ATP is also released during synaptic transmission (Smith, 199 I ; Zimmermann, 1994) . More than playing its ubiquitous role in energy supply, ATP has been proposed to be involved in intercellular signaling in various systems of the peripheral and central nervous systems (Sneddon et al., 1982; Sneddon and Burnstock, 1984; Lindgren and Smith, 1987; Benham, 1989; El-Moatassim et al., 1992; Evans et al., 1992; Salter and Hicks, 1994; Zimmermann, 1994; Lyons et al., 1995) . Among other mechanisms, ATP has been shown to increase intracellular Ca'* (O'Connor et al., 1991) either by releasing Ca"+ from internal stores or by regulating Ca'-entry. At the frog nmj, application of ATP on perisynaptic Schwann cells (PSC) induces the release of Cal' from internal stores (Jahromi et al., 1992) . The goal of this work was to characterize further the mechanisms responsible for the Ca?' responses evoked by ATP in PSCs of the frog nmj and examine the involvement of endogenous purines in the modulation of synaptic glial cells in situ.
There are two classes of purinoceptors based upon their selectivity to adenosine (PI receptors) and ATP (P2 receptors). Adenosine receptors are divided into two main groups, Al and A2 receptors, based on their ability to respectively inhibit or facilitate adenylate cyclase and also on their respective structureactivity and interactions with various drugs (Linden, 199 I ) . ATP receptors are divided in five groups. The Plx, P?,, and PL, receptors are permeable to various ions including Ca'+ , whereas PzY and Pz,, receptors mediate the release of Ca'+ from internal stores via G-binding proteins (G-protein) (Burnstock, 1990; O'Connor et al., 1991; Barnard et al., 1994) . Additional characterization has been achieved at the molecular level where three different genes for PzY receptors were cloned showing a strong homology to G protein-coupled receptors (Barnard et al., 1994) , two PzX receptors have been cloned showing homologies with the transmitter-gated ion channel superfamily (Barnard, 1992) and many adenosine receptors have been also identified at the molecular level (Miiller and Scior, 1993). We report here that PSCs at the frog nmj posses ATP and adenosine receptors. ATP but not adenosine receptors regulate nerve-evoked Ca'+ responses in PSCs.
Preliminary results have appeared (Robitaille, 1994) .
Materials and Methods
Experiments were performed on nmjs of cutaneous pectoris muscles of Rann pipiens frogs. Unless stated otherwise, the physiological solution contained (in mM): 120 NaCl, 2 KCI, I NaHCO,, 1.8 CaCl,, 5 HEPES. The pH was adjusted at 7.2.
Calciunz inzuging c$ PSCs. Nerve-muscle preparations were isolated from the frogs and pinned down in a recording chamber coated with Sylgard.
The membrane permeant form of the Ca2+ indicator fluo 3 (fluo 3-AM, Molecular Probes) was used. The fluorescence emitted by fluo 3 increases when it is bound to Ca?+ (Kao et al., 1989 (Jahromi et al., 1992 (Jahromi et al., , 1993 However, ecto-enzymes present in the synaptic cleft (Lai and Wong, 1991; Salter et al., 1993; Ziganshin et al., 1993) will dephosphorylate ATP to form adenosine. Since adenosine is an active substance in many cells, and at the frog nmj in particular (Silinsky, 1975; White, 1988; Meriney and Grinnell, 1991; Salter et al., 1993) , it is possible that the effects observed with ATP are due to the action of adenosine. To test for the presence of adenosine and ATP receptors, a series of experiments were performed to monitor the effects on Ca2+ responses of various agonists and antagonists of Pl and P2 receptors.
Adenosine induces Ca2+ responses in PSCs When applied locally, adenosine (10 (LM) induced Ca*+ responses (229 ? 42%; four muscles, 22 cells) in all PSCs tested. Figure 2 shows the Ca2+ level in one PSC before (Al), shortly after local application of adenosine (A2), and following recovery (arrows) of adenosine (10 pM) in presence of the Al antagonist CPT (2 PM). After washout of the antagonist (break in the x-axis), local application of adenosine (arrow) induced Ca2+ responses in the same two PSCs. C, Changes of fluorescence of two PSCs before and after application (arrow) of CPA (2 PM), an Al agonist. Each trace on the graphs illustrates the time course of the Ca2+ response for a PSC. D, Changes in fluorescence before and after local applications (arrows) of adenosine (10 FM) on five PSCs incubated for 14 hr with PTX (2 p&ml). Each line on the graph illustrates the time course of the Ca2+ response for a PSC. Note the absence of Ca2+ responses in these conditions. E, Images of two PSCs (arrows) before (I) and after (2) (Table 1 ). These results indicate that lack of responses was unlikely due to nonspecific effects of adenosine receptors are present on the PSCs and suggest that DPCPX since Ca*+ responses were evoked by local application CaZ+ responses evoked by ATP could be explained by the actiof the muscarinic agonist muscarine (1 pM) in presence of the vation of adenosine receptors.
Al antagonist (data not shown).
Adenosine receptors are of the Al subtype To determine the type(s) of adenosine receptors, we first used antagonists of Pl receptors. The antagonists were perfused on the preparation for at least 20 min prior to local applications of adenosine. The presence of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) (2 PM), a potent, specific Al receptor antagonist (Martinson et al., 1987; Linden, 1991; Miiller and Scion 1993) prevented the production of Ca*+ responses by adenosine in all cells tested ( Fig. 3A ; three muscles, 17 cells; 4 t 1%). The average Ca*+ response amplitude in presence of DPCPX was signifiSimilar results were obtained when 8-cyclopentyl-1,3-dimethylxanthine (WI), another Al antagonist (Bruns, 1990) , was used. Indeed, Ca*+ responses evoked by adenosine were greatly reduced when CPT (10 FM) was present in the perfusing solution (two muscles, 11 cells; 51 -+ 18%) (Fig. 3B) . These responses were significantly different from the responses obtained in absence of the antagonist (ANOVA analysis of variance, p < 0.05). Ca*+ responses to local application of adenosine were restored after washout of the antagonist (Fig. 3B) . At concentration of 100 nM, CPT still blocked Ca*+ responses induced by adenosine (52 +-43%; three muscles, 15 cells). The use of large Ca'+ responses induced by adenosine were also mimicked by an Al receptor agonist. The average increase in fluorescence evoked by N"-cyclopentyladenosine (CPA; I FM), a highly specific A I agonist, was similar to the ones obtained with adenosine ( Fig. 3C ; three muscles, 22 cells; 205 2 22%). This value was not statistically different from the size of the Ca?+ responses obtained with adenosine (ANOVA analysis of variance, p > 0.05). These results suggest that the adenosine receptors are of the Al type. A summary of the effects of Al agonists and antagonists is presented in Table I .
Adenosine releuses Ca2+ from internul stores via PTX-sensitive G-proteins in PSCs Al receptors are often coupled to G-proteins and regulate the release of Ca?' from internal stores through IP, receptors. To test whether adenosine receptors of the PSCs are coupled to a PTX-sensitive G-protein, muscles were incubated for 12-14 hr with 2 pg/ml of PTX, and the ability of adenosine to evoke Ca'+ responses was evaluated. No Ca?' responses were evoked in PSCs by adenosine after PTX treatment ( Fig. 30 ; four muscles, 30 cells; 23 5 9%), in 95% of the cells tested. Ca" responses were significantly smaller than the ones obtained in absence of PTX (ANOVA, p < 0.05) ( Table 1 ). It is unlikely that the lack of responses was due to the inability of PSCs to generate any responses after such treatment since local application of muscarine, known to release Ca" from internal stores via a PTX-insensitive mechanism (Jahromi et al. 1993), still induced Ca2+ responses after PTX treatment (data not shown). In addition, the presence of PTX at the nmjs was confirmed by the inability of adenosine to reduce the amount of transmitter released after treatment with PTX (Silinsky, 1975; Silinsky et al., 1990; Jahromi et al., 1993) .
We next tested whether Ca'+ responses mediated by Al receptors are due to the release of Ca" from internal stores. Preparations were incubated in 0 Ca"-5 mM Mg?+ physiological solution for 30 min prior to adenosine applications. Ca'+ responses could still be evoked by adenosine ( Fig. 3E ; three muscles, 19 cells), indicating that the source of Ca'* was from internal stores and did not require the entry of Ca?' into the PSCs. The size of Ca'+ responses (159 ? 26%) was not significantly different from the Ca'+ responses obtained in presence of external Ca'+ (Anova analysis of variance, p < 0.05) ( Table 1) . Similar results were obtained when EGTA (I mM) was added to the physiological solution to further reduce external Ca'+ concentration (data not shown). Hence, these results indicate that Al receptors of the frog PSCs are coupled to PTX sensitive G-proteins which regulate the release of Ca'+ from internal stores.
Are ATP receptors (P2) present on PSCsY Different P2 receptor agonists and antagonists were used to confirm the presence of ATP receptors on PSCs. The first attempts to test for the presence of P2 receptors on PSCs were performed using 2-methylthio-ATP (Me-S-ATP), an ATP analog which preferentially binds to P,, receptors (Cusack and Hourani, 1990; Salter and Hicks, 1993; Burnstock et al., 1994) . Local applications of Me-S-ATP (20 pM) induced Ca'+ responses (212 2 29%) in all cells tested (three muscles; 31 cells). Figure 4 , A and B, shows three PSCs at a nmj, before (AI) and shortly after application of Me-S-ATP (20 pM) (A2). Similar to adenosine, Ca'+ responses evoked by Me-S-ATP were not significantly different from the responses evoked by ATP (ANOVA, analysis of variance, p > 0.05) ( Table I ). It is possible that the responses evoked by Me-S-ATP are mediated through a Pzr, receptor since this agonist has some affinity for the P2L, receptor (Salter and Hicks, 1994) . This is unlikely since the application of UTP, the agonist for Pzu receptor, did not evoke any Ca?' responses in the PSCs (data not shown). However, because Me-S-ATP is hydrolyzable, it is possible that part of its effect was due to activation of adenosine receptors.
To further confirm the presence of ATP receptors on PSCs we used L-adenylyl 5'-(P,y-methylene)diphosphate (L-AMP-PCP), an ATP analog with a higher affinity to PLx receptors (Cusack and Hourani, 1990) . On the contrary to Me-S-ATE L-AMP-PCP is resistant to dephosphorylation (Hourani et al.. 1986 ) and, hence, will prevent the formation of adenosine by the ecto-enzymes. Figure 4C illustrates Fig. 40 ; four muscles. 22 cells; I9 ? 6%). Only 50% of the cells were blocked when suramin was used at a concentration of 100 pM. The blockade of Ca2+ responses by suramin was reversible and responses could be obtained after removal of the antagonist (Fig. 40) . Similarly, Ca'+ responses evoked by L-AMP-PCP (50 FM) were reversibly blocked by suramin (100 FM) (three muscles, I4 cells; 10 ? 4%) (Fig. 4E, Table I ). However, adenosine (IO FM) still induced Ca?+ responses in presence of suramin (2 I5 t 20; three muscles, six cells) (ANOVA, p > 0.05) (Table 1) . Moreover, Ca2+ responses elicited by ATP analogs were not blocked by the Al antagonist, DPCPX (Table I) indicating that the adenosine receptors are not blocked by suramin. These results indicate that Ca'+ responses evoked by ATP and its agonists are likely due to the activation of P2 receptors.
The next step consisted in determining whether the two agonists act on the same P2 receptor or on different ones. To do so, the cellular mechanisms responsible for the production of the Ca? + responses were examined. Pz, receptors would be expected to regulate the release of Ca 2+ from internal stores whereas Pzx receptors are expected to mediate Ca'+ entry into the cells either directly through the receptor or by activating voltage-dependent Ca?+ channels due to membrane depolarization (Bean, 1992; Zimmerman, 1994) .
Me-S-ATP releases Ca" from internul stores via PTX-sensitive G-proteins in PSCs
The cellular mechanisms involved in the responses induced by Me-S-ATP were first examined. PTX was used to determine whether a PTX-sensitive G-protein was involved in the production of the CaZ+ responses. After incubation with PTX (2 p+g/ ml), Ca" responses evoked by Me-S-ATP (20 FM) were greatly diminished ( Fig. 5A ) (four muscles, 48 cells; 29 +-6%). Ca" (Bumstock, 1990; Salter et al., 1993) . Furthermore, unlike PzY receptors, P,, receptors are generally not coupled to G-proteins (Barnard et al., 1994) . The involvement of PTX-sensitive G-proteins was first tested. Local applications of L-AMP-PCP (50 PM), still evoked Ca*+ responses after PTX treatment (126 + 24%; 16/17 cells; Fig.  5C ) (ANOVA, p > 0.05) ( Table 1 ). The absence of effect is not due to PTX inefficacy since no Ca2+ responses were evoked by adenosine on the same preparations (data not shown).
The requirement of external Ca*+ for the genesis of Ca2+ responses was tested by replacing Ca*+ ions by Mg*+ ions. Ca*+ responses evoked by L-AMP-PCP (50 FM) were greatly reduced (25 +-9%; three muscles, 20 cells) (Fig. 5D, Table 1 ). Upon addition of external Ca*+ (break in the x-axis), the ability of L-AMP-PCP (50 PM) to evoke Ca*+ responses was restored (Fig. 5D) . The entry of Ca*+ was further tested by using Cd2+ (20 FM), an ion competing for many Ca*+-binding sites (Bean, 1992) . Ca*+ responses evoked by L-AMP-PCP in presence of Cd2+ were significantly reduced (12 + 8%; three muscles, 19 cells; ANOVA, p < 0.05) ( Table 1) . These results indicate that L-AMP-PCP induced Ca*+ entry via a PTX-insensitive mechanism and are consistent with the activation of P,, receptors.
Hence, the different cellular mechanisms regulating Ca*+ responses evoked by Me-S-ATP and L-AMP-PCP suggest that P,, and P,, receptors are present on PSCs.
L-AMP-PCP mediates Ca2+ entry mainly through L-type Ca2+ channels The possible involvement of Ca*+ channels in the entry of Ca*+ induced by L-AMP-PCP was next investigated. Ca*+ channels are present in many glial cells and in PSCs in particular (Barres et al., 1990; MacVicar et al., 1991; Jahromi et al., 1992) entering the cells through P,, receptors. The ability of L-AMP-PCP to evoke Ca2+ responses was monitored in presence of various L-type Ca*+ channel antagonists, the most common Ca*+ channels in glial cells (Barres et al., 1990; MacVicar et al., 1991) . In the presence of the antagonist enantiomer of Bay K 8644, R(+) Bay K 8644 (2-20 PM), (Ferrante et al., 1989; van Amsterdam et al., 1989; Ravens et al., 1990) , Ca*+ responses induced by L-AMP-PCP (50 FM) were reduced by 80% (five cells, three muscles; 25 ? 12%) ( Table 1 ). This reduction was reversible upon washout of the Ca*+ channel antagonist. Similar results were obtained with nimodipine (2 (IM) (Robitaille et al., 1995) . These results indicate that Ca*+ entry induced by L-AMP-PCP, likely due to P,, receptor activation, is mainly the result of L-type Ca*+ channels activation due to membrane depolarization.
Modulation of Ca2+ responses by endogenous purines
The involvement of endogenous purines in triggering Ca2+ responses in PSCs during synaptic transmission was next examined. Transmitter release was evoked by repetitive stimulations of the motor nerve at 50 Hz. On average, Ca'+ responses were 326 + 59% (three muscles, seven cells) (Table l) , the delay before the onset was 3.3 + 0.5 set and the time to reach the maximum amplitude was 19 t 5 set (Fig. 6A,B) . As shown in our previous study (Jahromi et al., 1992) , nerve-evoked Ca*+ responses show a progressive rundown during successive stimulations (Fig. 6C, solid circles) . Because of that characteristic, the effects of different blockers on nerve-evoked Ca2+ responses were tested on different preparations and each preparation was only stimulated once. The presence of the Al antagonist DPCPX (20 FM) had no effect on any of the parameters of the Ca*+ responses evoked by nerve stimulations (average of 396 t 69%, delay of 4.1 ? 1.2 set, time to peak of 17 + 6 set; three muscles, six cells).
However, Ca*+ responses evoked by local applications of adenosine were blocked in these conditions, indicating that the adenosine receptors were blocked. Because Al receptors often produce inhibitory actions (Silinsky et al., 1990; Edwards and Gibb, 1993) , we hypothesized that the rundown of Ca?+ responses could be caused by the activation of Al receptors. As shown in t local applications (arrows) of Me-S-ATP (20 pM) following 13 hr of incubation with PTX (2 pg/ml). Each trace on the graphs illustrates the time course of the Caz+ response for a PSC. Note that no Ca2+ responses were evoked in these conditions. B, Images of one PSC (arrow) before (I) and after (2) Figure 6C (solid squares; four cells, three muscles), the rate of rundown as well as the degree of attenuation was the same whether Al receptors were blocked or not. Thus, these results suggest that adenosine receptors do not modulate directly the Ca2+ responses induced by nerve evoked transmitter release.
We next tested whether ATP receptors modulate nerve-evoked Ca*+ responses of the PSCs. Blockade of ATP receptors with suramin (200 PM) produced major changes in Ca*+ responses evoked by nerve stimulations (Fig. 60) . Ca2+ responses were reduced to 87 -t 45% (five muscles, seven cells), which is statistidally different from the control value (ANOVA, p < 0.05) ( Table 1 ). In addition, the delay before the onset of the responses was significantly increased to 16 + 4 set, but the time to reach the maximum amplitude was not significantly different (14 I? 3 set; ANOVA, p > 0.05). The effect on the rundown of the Ca*+ responses could not be tested convincingly because the initial responses would often be too small. On four cells tested, aden- Time (s) osine (10 FM) could still evoke Ca2+ responses after the train of stimuli indicating that the cells were responsive and that the suramin effects are not due to blockade of adenosine receptors. These experiments indicate that the activation of ATP receptors, but not adenosine receptors, is necessary for optimal Ca*+ responses in the PSCs during synaptic transmission.
Discussion
The results of the present study reveal the presence of various purinoceptors at PSCs of the frog nmj and that these receptors are activated by endogenous ATP released by the nerve terminal during synaptic activity.
Different purinoceptors on the PSCs
Although the complete pharmacological characterization of the purinoceptors could not be achieved due to the presence of ectoenzymes (Smith. 1991) and the difficulty to block them all (Zi-ganshin et al., 1993 ) the results of the present study support the fact that there are several types of purinoceptors in PSCs. For instance, the cellular mechanisms generating the Ca*+ responses vary according to the agonist used. L-AMP-PCP mediates Ca*+ entry whereas adenosine and Me-S-ATP induce the release of Ca*+ from internal stores. Moreover, the action of Pl and P2 receptor blockers is specific for their respective receptor type. This rules out possible actions of ATP agonists on adenosine receptors and strongly suggest that ATP and adenosine receptors are present in PSCs. The characterization of P2 receptors is difficult owing to the lack of specific agonists and antagonists. However, the different cellular mechanisms producing the Ca*+ responses suggest that there are two types of ATP receptors on PSCs. Responses induced by Me-S-ATP correspond more to a PzY receptor as suggested by the release of Ca *+ from internal stores via G-protein mechanisms whereas responses induced by L-AMP-PCP correspond more to a P,, receptor owing to the induction of Ca*+ entry directly through the receptors and L-type Ca*+ channels. Hence, we conclude that PSCs at the frog nmj have three types of purinoceptors which mediate Ca2+ responses.
Specijicity of pharmacological agents
The pharmacological tools available to study ATP receptors are limited and their specificity of action is not always clear. For instance, suramin has been shown to inhibit ecto-ATPase activity (Voogd et al., 1993; Ziganshin et., 1994) and 5'-adenylylimidodiphosphate (AMP-PNP), an ATP analog related to L-AMP-PCP has been found to inhibit the activity of ecto-ADPase (James and Richardson, 1993). In both cases, endogenous ATP or locally applied ATP would remain in the synaptic cleft longer and, hence, show more potency activating all P2 receptors. This is unlikely in the present study since Ca2+ responses were completely and reversibly blocked by suramin, indicating that ATP receptors were blocked. Moreover, the mechanisms producing Ca*+ responses induced by L-AMP-PCP are different from the responses evoked by Me-S-ATE suggesting a specific action at P,, receptors. The presence of ectoprotein-kinases on the surface of several cells (Ehrlich et al., 1986 (Ehrlich et al., , 1994 Zimmermann, 1994) raises the possibility that Ca*+ responses induced by ATP are secondary to the action of an ectoprotein-kinase. This is unlikely because Ca'+ responses were obtained in absence of Mg2+, a cation required for the function of the enzyme (Ehrlich et al., 1986) . Moreover, Ca*+ responses induced by ATP analogs were blocked by suramin, which further supports the involvement of ATP receptors.
Adenosine receptor pharmacology is better characterized (Daly et al., 1985; Hourani et al., 1986; Martinson et al., 1987; Bruns, 1990; Paton and Taerum, 1990; Linden, 1991; Stiles, 1992; Miiller and Scior, 1993) . The present results are consistent with the adenosine receptor being of the Al subtype since A2 antagonists had no effects on Ca*+ responses evoked by adenosine whereas the responses were blocked by Al antagonists and mimicked by an Al agonist at concentrations similar or lower than the ones used in other studies (Silinsky et al., 1990; Meriney and Grinnell, 1992; Kriegler and Chiu, 1993; Salter et al., 1993; Sanger et al., 1993; Abbracchio et al., 1994 Figure 7 . Model of purinoceptor activation at PSCs of frog nmj. Diagram illustrating a portion of a nerve terminal at an active zone (AZ) surrounded by synaptic vesicles (SV). A Schwann cell process (SCP) is located at proximity of the active zone. The postsynaptic element has been omitted for clarity. ATP is coreleased with ACh during synaptic transmission (1) and can activate P,, and P,, receptors (2). ATP will also be degraded to adenosine by the various ecto-enzymes (3). Activation of P,, receptors by ATP will induce CaZ+ entry partly through the ATP receptor itself but mainly through L-type Ca*+ channels (4). Activation of P,, receptors by ATP will trigger the release of Ca*+ from internal stores through the activation of a PTX-sensitive G-protein (5,8). Activation of Al adenosine receptors (6) will result in the release of Ca2+ from internal stores mediated by the activation of a PTX-sensitive G-protein (7-8).
1992; Edwards and Gibb, 1993; Salter et al., 1993; Backus et al., 1994; Chen et al., 1994; Zimmermann, 1994) and, hence, ATP released during nerve-evoked synaptic transmission may also quickly activate the PSCs. In the present study, it is shown that endogenous ATP released during synaptic transmission modulates the activity of the PSCs. This regulatory effect of ATP is probably underestimated since the activation of the muscle fibers, providing approximately 50% of the total ATP (Smith, 1991), was prevented by blocking the postsynaptic receptors. The presence of multiple purinoceptors implies that ATP activates multiple cellular pathways and control various cellular functions. Owing to the nature of the various cellular mechanisms and the enzymatic cascade required to produce adenosine from ATP one may propose the following scheme.
Upon release from the nerve terminal (Fig. 7, step l) , ATP may act directly on two different receptors, P,, and P,, (step 2). ATP will also be dephosphorylated by the ecto-enzymes to form adenosine (step 3). It is quite likely that Ca*+ entry mediated by the P,, receptors will occur prior to Ca*+ released by the activation of P,, receptors because P,, receptors are directly permeable to Ca*+ and indirectly activate L-type Ca2+ channels (step 4) whereas PzY receptors act by a slow process involving Ca*+ release from internal stores via second messengers and G-protein activation (steps 5 and 8) (Barnard et al., 1994; Burnstock et al., 1994) . Due to ATP and ADP inactivation of 5'-nucleotidase (Zimmermann, 1992 (Zimmermann, , 1994 causing delay in the apparition of adenosine, the activation of adenosine receptors (step 6) would occur later, after degradation of ATI? It will also lead to the activation of a G-protein (step 7) and the release of Ca2+ from internal stores (step 8), provided that the stores were not depleted by the activation of PzY receptors. The activation of adenosine receptors is hypothetical since no evidence was obtained in the present study. Al and P2 receptors likely have different regulating mechanisms since ATP but not adenosine antagonists modulated the nerve-evoked Ca*+ responses in PSCs. We hypothesize that the early activation of P,, receptors engages a cascade of events that will be completed or terminated
